Abstract OBJECTIVES: This article discusses how participatory technology appraisal as part of the Universal Coverage Scheme (UCS) in Thailand contribu ...Read more
Abstract Background There is very limited evidence examining serious systemic adverse events (SSAEs) and post-injection endophthalmitis of intravitrea ...Read more
Abstract Background To evaluate the effectiveness of intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) in actual practice for treating ...Read more
Abstract BACKGROUND: At present, health technology assessment (HTA) guidelines of many countries including Thailand have recommended EQ-5D as the pref ...Read more
Abstract Aim Alcohol related disease conditions are responsible for a significant proportion of morbidity and mortality in Sri Lanka. This study quant ...Read more
Abstract BACKGROUND: Structural chromosome abnormalities can cause significant negative reproductive outcomes as they typically result in morbidity an ...Read more
Abstract Background Due to competing health priorities and limited resources, many low-income countries, even those with a high disease burden, are no ...Read more
Abstract Thailand is encountering challenges to introduce the high-cost sofosbuvir for chronic hepatitis C treatment as part of the Universal Health C ...Read more
The use of economic evaluation in healthcare policies and decision-making, which is limited in low- and middle-income countries (LMICs), might be prom ...Read more
Primary care serves as an entry point in the Thai health care system. Whilst effective interventions are provided in the primary care setting, the qua ...Read more
Health Intervention and Technology Assessment Program Foundation
Head Office : 88/22 Moo 4, 6th Building, 6th Floor, Department of Health, Ministry of Public Health, Tiwanon Road, Taladkwan Subdistrict, Muang Nonthaburi District, Nonthaburi 11000, Thailand
Tel. : +662-590-4549, +662-590-4374-5
Fax : +662-590-4369
E-mail : [email protected]
Website : www.hitap.net
